Welcome to Cell Medica

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for cancer and infectious diseases.

About

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer and immune reconstitution following hematopoietic stem cell transplant.

Read More...

News

Cell Medica and Baylor College of Medicine expand partnership to develop allogeneic CAR-NKT cells for cancer treatment

Read More...

Cell Medica and UCL collaborate to develop modified T cell receptor products for the treatment of cancer

Read More...

Lead cancer immunotherapy candidate granted EU orphan drug designations

Read More...

Products

As a company, we are committed to making the widespread use of cellular immunotherapy in the fight against cancer and viral infections a reality. We are doing this by developing an industry leading pipeline of naturally occurring and gene-modified immune cell products that can meet medical need.

Read More...